Botond Roska got a €1 million check from a Germany Foundation (Korber) for his groundbreaking research. The treatment which is going to restore sight has already gotten to the clinical trial stage.
He came up with a gene-based therapy that reprograms cells in the human eye so that they can perform the work of the light-sensitive receptors needed for human vision.
Roska said, For the time being, the process creates a level of vision similar to watching television in black and white. Clinical tests on blind volunteers are already underway as a result of the groundbreaking research work.
Roska’s groundbreaking research has given the blind hope that this new treatment method might restore their ability to see the beautiful world around them.